Cutaneous accumulation of abnormal polyglutamine proteins of patients with dentatorubral-pallidoluysian atrophy. 2009

M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

OBJECTIVE Dentatorubral-pallidoluysian atrophy (DRPLA) is a hereditary spinocerebellar degeneration caused by expansion of a trinucleotide CAG repeat encoding a polyglutamine tract in a disease protein atrophin-1. The clinical features include ataxia, choreoathetosis, and dementia, which result from neural degeneration caused by the mutant atrophin-1. METHODS We performed skin biopsy in two patients with DRPLA. RESULTS We found multiple clear cells in the epidermis, which were positive for proteins containing an expanded polyglutamine stretches. The clear cells were p63 (+), S-100 (-), and cytokeratin 20 (-), showing that they were keratinocytes. Negative or weak signals of pan-cytokeratin were consistent with the finding of decreased tonofilaments at the electron microscopic level. CONCLUSIONS The presence of clear keratincoytes showed that the mutant proteins interfered in cellular functions not only in neural cells but also in keratinocytes. The skin is accessible by biopsy, making it important in the diagnosis. Furthermore, the polyglutamine staining in the skin may be useful for evaluation of therapeutic modalities for DRPLA and other polyglutamine diseases.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D013194 Staining and Labeling The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts. Histological Labeling,Staining,Histological Labelings,Labeling and Staining,Labeling, Histological,Labelings, Histological,Stainings
D015603 Keratinocytes Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Keratinocyte
D018911 Trinucleotide Repeats Microsatellite repeats consisting of three nucleotides dispersed in the euchromatic arms of chromosomes. Triplet Repeats,Repeat, Trinucleotide,Repeat, Triplet,Repeats, Trinucleotide,Repeats, Triplet,Trinucleotide Repeat,Triplet Repeat
D020191 Myoclonic Epilepsies, Progressive A heterogeneous group of primarily familial EPILEPSY disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis (see MUCOLIPIDOSES), and UNVERRICHT-LUNDBORG SYNDROME. Action Myoclonus-Renal Failure Syndrome,Biotin-Responsive Encephalopathy,Dentatorubral-Pallidoluysian Atrophy,May-White Syndrome,Ataxia, Chorea, Seizures, And Dementia,Atypical Inclusion-Body Disease,Familial Progressive Myoclonic Epilepsy,Haw River Syndrome,Myoclonic Epilepsy, Progressive,Myoclonus-Nephropathy Syndrome,Naito Oyanagi Disease,Naito-Oyanagi Disease,Progressive Myoclonic Epilepsy,Progressive Myoclonus Epilepsies,Action Myoclonus Renal Failure Syndrome,Atrophies, Dentatorubral-Pallidoluysian,Atrophy, Dentatorubral-Pallidoluysian,Atypical Inclusion Body Disease,Atypical Inclusion-Body Diseases,Biotin Responsive Encephalopathy,Biotin-Responsive Encephalopathies,Dentatorubral Pallidoluysian Atrophy,Dentatorubral-Pallidoluysian Atrophies,Encephalopathies, Biotin-Responsive,Encephalopathy, Biotin-Responsive,Epilepsies, Progressive Myoclonic,Epilepsies, Progressive Myoclonus,Epilepsy, Progressive Myoclonic,Epilepsy, Progressive Myoclonus,Haw River Syndromes,Inclusion-Body Disease, Atypical,Inclusion-Body Diseases, Atypical,May White Syndrome,Myoclonus Epilepsies, Progressive,Myoclonus Nephropathy Syndrome,Myoclonus-Nephropathy Syndromes,Naito-Oyanagi Diseases,Progressive Myoclonic Epilepsies,Progressive Myoclonus Epilepsy,River Syndromes, Haw,Syndromes, Myoclonus-Nephropathy

Related Publications

M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
November 2002, Annals of neurology,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
January 2002, Ryoikibetsu shokogun shirizu,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
January 2012, Handbook of clinical neurology,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
January 2011, Handbook of clinical neurology,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
January 2004, Nihon rinsho. Japanese journal of clinical medicine,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
March 1997, Neuroscience letters,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
August 1996, Neurology,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
August 2006, Neuropathology : official journal of the Japanese Society of Neuropathology,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
August 1998, Biochemical and biophysical research communications,
M Ohta, and R Okuyama, and E Ogawa, and K Kisu, and H Sato, and M Aoki, and S Aiba
November 2007, Rinsho shinkeigaku = Clinical neurology,
Copied contents to your clipboard!